Detalhe da pesquisa
1.
Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons.
BMC Infect Dis
; 22(1): 380, 2022 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35428213
2.
Gender differences among persons entering medication treatment for opioid use disorder in the community.
Am J Addict
; 31(5): 390-395, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35652902
3.
Sexual Violence and Chemsex among Substance-Using Sexual and Gender Minorities in Texas.
Subst Use Misuse
; 56(14): 2141-2150, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34550052
4.
HIV-infected men who have sex with men, before and after release from jail: the impact of age and race, results from a multi-site study.
AIDS Care
; 28(1): 22-31, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26275122
5.
Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non-Clinicians.
Psychiatr Res Clin Pract
; 5(3): 78-83, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37711754
6.
The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV.
Drug Alcohol Depend Rep
; 7: 100159, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37159815
7.
Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder.
J Subst Abuse Treat
; 142: 108852, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35988513
8.
Evaluation of the Impact of HIV Serostatus on the Hepatitis C Virus Care Cascade and Injection Drug Use Among Persons Initiating Medication Treatment for Opioid Use Disorder.
Open Forum Infect Dis
; 9(11): ofac624, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36467300
9.
Covariates of hazardous alcohol use among sexual and gender minorities in Texas: Identifying the most vulnerable.
Addict Behav
; 105: 106327, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32044679
10.
A modeling framework to inform preexposure prophylaxis initiation and retention scale-up in the context of 'Getting to Zero' initiatives.
AIDS
; 33(12): 1911-1922, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31490212
11.
Corrigendum to 'Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder' [J. Subst. Abuse Treat. vol. 142 (2022)/108852].
J Subst Use Addict Treat
; 150: 209074, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37271717
12.
Extended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community: Results From a Double-Blind, Placebo-Controlled Trial.
J Acquir Immune Defic Syndr
; 79(1): 92-100, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29781884
13.
Substance Use, Mental Health, HIV Testing, and Sexual Risk Behavior Among Men Who Have Sex With Men in the State of Maharashtra, India.
AIDS Educ Prev
; 30(2): 96-107, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29688773
14.
Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.
J Acquir Immune Defic Syndr
; 78(1): 43-53, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29373393
15.
Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community.
Drug Alcohol Depend
; 174: 158-170, 2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28334661
16.
Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system.
Drug Alcohol Depend
; 157: 158-65, 2015 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26560326
17.
Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community.
Contemp Clin Trials
; 37(2): 209-18, 2014 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24384538
18.
Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community.
Contemp Clin Trials
; 39(2): 256-68, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25240704
19.
A comparison of psychiatric diagnoses among HIV-infected prisoners receiving combination antiretroviral therapy and transitioning to the community.
Health Justice
; 2(11)2014 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25606368
20.
An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone.
J Subst Abuse Treat
; 47(1): 35-40, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24674234